Search - tctmd.com

Displaying 61 - 80 of 227

Sort: Relevancy | Date

News Conference News AHA 2023

New PCSK9 Inhibitor Halves LDL: Will Protracted Dosing Make a Difference?

Shelley Wood

November 13, 2023

News Conference News AHA 2023

Inflammation More Powerful Than LDL as CV Risk Predictor in Statin-Free Patients

Caitlin E. Cox

November 07, 2023

News Opinion Editor's Corner AHA 2023

What’s Going to Be Hot at AHA 2023

Shelley Wood

November 07, 2023

News Daily News

Pooled Cohort Equations Work in Real-world Patients, Even Outliers

Yael L. Maxwell

October 12, 2023

News Daily News

To Curb Secondary Event Risk, Go ‘Granular’ With Causes of TIA, Minor Stroke

Todd Neale

October 03, 2023

News Daily News

Aggressive Lipid-Lowering Very Unlikely to Hurt the Brain: AHA

Todd Neale

September 19, 2023

News Daily News

TCTMD’s Michael O’Riordan Wins Digital Health Award

Shelley Wood

August 22, 2023

News Daily News

Acute MI Patients Without Standard CVD Risk Factors at Higher Risk of Death

Michael O'Riordan

July 07, 2023

News Conference News EAS 2023

Variable Response to Novel PCSK9 Inhibitor Lerodalcibep in LIBERATE-HoFH

Michael O'Riordan

May 24, 2023

News Daily News

Oxidized Phospholipids and Lp(a) Strongly Associated With MACE: CASABLANCA

Michael O'Riordan

May 03, 2023

News Daily News

Not All Diets Measure Up for Protecting the Heart: AHA

Caitlin E. Cox

April 28, 2023

News Daily News

AI Gleans Insights Into Statin Questions, Misinformation Online

L.A. McKeown

April 26, 2023

News Daily News

Longer-Term ASCVD Risk Assessment Best for Younger Patients

Michael O'Riordan

February 16, 2023

News Opinion CV Team Dispatch

January 2023 News Roundup

L.A. McKeown

January 16, 2023

News Daily News

Semaglutide Effective for Weight Loss in Adolescents: STEP TEENS

Michael O'Riordan

December 30, 2022

News Daily News

Top General Cardiology and Prevention News of 2022

Michael O'Riordan

December 26, 2022

News Daily News

How Lp(a) Levels Compare With LDL-C in FH: Some Surprises

Michael O'Riordan

November 17, 2022

News Conference News AHA 2022

‘Dramatic’ Reductions in Lp(a) With Olpasiran: OCEAN(a)-DOSE

Michael O'Riordan

November 06, 2022

News Conference News AHA 2022

Pemafibrate Fails to Lower CVD Risk in Patients With High Triglycerides: PROMINENT

Michael O'Riordan

November 05, 2022

News Features

Novel Targets, Gene Edits, and Vaccines: Is a ‘Golden Era’ Dawning for ASCVD?

Michael O'Riordan

August 15, 2022

Advertisement

New PCSK9 Inhibitor Halves LDL: Will Protracted Dosing Make a Difference?

Inflammation More Powerful Than LDL as CV Risk Predictor in Statin-Free Patients

What’s Going to Be Hot at AHA 2023

Pooled Cohort Equations Work in Real-world Patients, Even Outliers

To Curb Secondary Event Risk, Go ‘Granular’ With Causes of TIA, Minor Stroke

Aggressive Lipid-Lowering Very Unlikely to Hurt the Brain: AHA

TCTMD’s Michael O’Riordan Wins Digital Health Award

Acute MI Patients Without Standard CVD Risk Factors at Higher Risk of Death

Variable Response to Novel PCSK9 Inhibitor Lerodalcibep in LIBERATE-HoFH

Oxidized Phospholipids and Lp(a) Strongly Associated With MACE: CASABLANCA

Not All Diets Measure Up for Protecting the Heart: AHA

AI Gleans Insights Into Statin Questions, Misinformation Online

Longer-Term ASCVD Risk Assessment Best for Younger Patients

January 2023 News Roundup

Semaglutide Effective for Weight Loss in Adolescents: STEP TEENS

Top General Cardiology and Prevention News of 2022

How Lp(a) Levels Compare With LDL-C in FH: Some Surprises

‘Dramatic’ Reductions in Lp(a) With Olpasiran: OCEAN(a)-DOSE

Pemafibrate Fails to Lower CVD Risk in Patients With High Triglycerides: PROMINENT

Novel Targets, Gene Edits, and Vaccines: Is a ‘Golden Era’ Dawning for ASCVD?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content